Table 2.
Cardiological publications presenting examples for the important role of plakophilin-2 in the development of arrhythmogenic ventricular cardiomyopathies (ARVC), including “sudden death”
| Gerull et al. 2004 | Lahtinen et al. 2008 | Fressart et al. 2010 |
| Antoniades et al. 2006 | Ram and van Wagoner 2008 | van der Zwaag et al. 2010 |
| Awad et al. 2006 | Tandri et al. 2008 | Xu et al. 2010 |
| Basso et al. 2006 | Yu et al. 2008 | Aneq et al. 2011 |
| Calkins 2006 | Bhuiyan et al. 2009 | Basso 2011 |
| Dalal et al. 2006 | den Haan et al. 2009 | Calkins 2011 |
| Kannankeril et al. 2006 | Hall et al. 2009 | Gandjbakhch et al. 2011 |
| Nagaoka et al. 2006 | Qiu et al. 2009 | Lahtinen et al. 2011 |
| Syrris et al. 2006 | Watkins et al. 2009 | Li et al. 2011 |
| Tsatsopoulou et al. 2006 | Wu et al. 2009 | Lombardi and Marian 2011 |
| van Tintelen et al. 2006 | Barahona-Dussault et al. 2010 | Paul et al. 2011 |
| Otterspoor et al. 2007 | Bauce et al. 2010 | Rickelt et al. 2011b |
| Sen-Chowdhry et al. 2007 | Christensen et al. 2010a | van Tintelen 2011 |
| Fidler et al. 2008 | Christensen et al. 2010b | |
| Joshi-Mukherjee et al. 2008 | Cox et al. 2010 |